IPSC

NASDAQStock

Century Therapeutics, Inc.

$2.31-0.18 (-7.40%)

52-Week Range

$0.39

$2.94

Key Stats

Market Cap

202.3M

P/E Ratio

—

Dividend Yield

—

Beta

1.72

Volume

989.3K

Avg Volume

1.2M

Performance

+42.86%

+337.14%

+402.82%

YTD

+151.28%

+319.25%

-37.19%

-89.05%

Price Chart

ETF Exposure

IPSC is held by 8 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
AVSC	Avantis U.S. Small Cap Equity ETF	0.01%	42,570	$106K	$2.36B	0.25%
VXF	Vanguard Extended Market ETF	0.00%	539,662	$1.0M	$84.10B	0.05%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	74	$190	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	2,647	$7K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	12	$32	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	1,507,306	$2.9M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	7,928	$20K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	683	$2K	$1.29B	0.17%

About IPSC ETF Exposure

Century Therapeutics, Inc. (IPSC) is held by 8 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 202.3M, IPSC is a widely held institutional stock. The stock currently trades at $2.31. Investors can gain exposure to IPSC through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold IPSC, sorted by portfolio weight.